In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Fans were gripping fences all Sunday morning as the sounds of racecars serenaded the tens of thousands who flocked to IndyCar’s inaugural Java House Grand Prix of Arlington. Kyle Kirkwood won the race ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...
KUNSHAN, China--A glimpse of what the future of flying taxis might look like can be seen in this southeastern Chinese city. In a hangar in Kunshan, more than 60 kilometers (about 37 miles) west of the ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results